STOCK TITAN
  1. Home
  2. Sec-filings
  3. NPCE
  4. [Form 4] NeuroPace Inc Insider Trading Activity

NeuroPace (NPCE) director Fischer receives stock and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

NeuroPace Inc director Frank M. Fischer received equity compensation consisting of common stock and stock options. He was granted 2,890 shares of common stock at no cost, increasing his direct holdings to 598,067 shares. He was also granted options for 5,368 shares at an exercise price of $15.74 per share, expiring on June 4, 2036.

Both the shares and options vest in twelve equal monthly installments, contingent on his continuous service, which makes this a scheduled, compensation-related award rather than a market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Fischer Frank M
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 5,368 $0.00 --
Grant/Award Common Stock 2,890 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 5,368 shares (Direct, null); Common Stock — 598,067 shares (Direct, null)
Footnotes (1)
  1. The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.
Common stock grant 2,890 shares Award of NeuroPace common stock to director
Holdings after grant 598,067 shares Common stock directly held by Frank M. Fischer after award
Stock options granted 5,368 options New stock option (right to buy) grant
Option exercise price $15.74 per share Conversion/exercise price for 5,368 stock options
Option expiration June 4, 2036 Expiration date of newly granted stock options
Vesting schedule shares 12 monthly installments Common stock award vesting pattern, subject to continuous service
Vesting schedule options 12 monthly installments Option shares vesting and becoming exercisable over 12 months
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: "15.7400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The shares shall vest in twelve (12) equal consecutive monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service through each vesting date"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fischer Frank M
(Last)(First)(Middle)
C/O NEUROPACE, INC.
455 N. BERNARDO AVENUE
(Street)
MOUNTAIN VIEW CALIFORNIA 94043
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
NeuroPace Inc [ NPCE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/05/2026A2,890(1)A$0598,067D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$15.7406/05/2026A5,368 (2)06/04/2036Common Stock5,368$05,368D
Explanation of Responses:
1. The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date.
2. The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date.
Remarks:
/s/ Leah Akin, Attorney-in-Fact06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did NeuroPace (NPCE) director Frank M. Fischer report in this Form 4?

Frank M. Fischer reported equity compensation awards. He received 2,890 shares of NeuroPace common stock and stock options for 5,368 shares, both granted at no cash cost to him as part of his director compensation package.

How many NeuroPace (NPCE) shares does Frank M. Fischer hold after this grant?

After the grant, Frank M. Fischer directly holds 598,067 shares of NeuroPace common stock. The 2,890-share award increased his existing position, and is separate from the 5,368 underlying shares subject to the newly granted stock options.

What are the key terms of the stock options granted to Frank M. Fischer at NeuroPace (NPCE)?

Fischer received stock options covering 5,368 NeuroPace shares with a $15.74 exercise price. These options expire on June 4, 2036, and the underlying shares vest in twelve equal monthly installments, subject to his continued service with the company.

How do the new NeuroPace (NPCE) equity awards to Frank M. Fischer vest over time?

Both the 2,890-share common stock award and the 5,368-share option grant vest in twelve equal monthly installments. Each installment requires Frank M. Fischer to remain in continuous service through the applicable vesting date with NeuroPace.

Were the NeuroPace (NPCE) Form 4 transactions open-market buys or sells?

The transactions were not open-market buys or sells. They are coded as “A” awards, representing grants of common stock and stock options as compensation, with no purchase or sale of shares on the open market by Frank M. Fischer.